Jaked, I did read your post...
You said: "Rather than apply all available funds to their own direct exploration projects, they have made investments in other listed companies as a secondary means of having exposure to projects there with upside."
Jaked, we can all do that. You could pay a part time bookkeeper to maintain that portfolio. These guys just don't want to get their hands dirty. Its meant to be a mining company.
You said: "However, the BIG catalyst now is in the form of their investment in DANAKALI and its immediate prospects to deliver to MZM an enormous cash injection from what I believe will emanate as a result of a take-over of DNK within the next 12 months at a minimum of $ 2.50 / DNK share, thus providing MZM with a potential cash injection of around $ 25 million or $ 0.30 for each MZM share. Upon this event unfolding, MZM shares being tightly held would SOAR and in my opinion they would hit a new all time HIGH..ie: above $ 0.96 per MZM share."
Jaked, the share price is $0.13. I can't see how a cash injection of $0.30 per share will take it above $0.96. Would be $0.43 at best but maybe $0.35 after tax.
Cheers,
Von.
- Forums
- ASX - By Stock
- Montezuma update and potential
Jaked, I did read your post... You said: "Rather than apply all...
-
- There are more pages in this discussion • 4 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add E25 (ASX) to my watchlist
|
|||||
Last
23.5¢ |
Change
0.000(0.00%) |
Mkt cap ! $51.67M |
Open | High | Low | Value | Volume |
0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 24468 | 23.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
25.0¢ | 1957 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 24468 | 0.235 |
2 | 41387 | 0.215 |
6 | 276670 | 0.210 |
2 | 35000 | 0.205 |
10 | 466004 | 0.200 |
Price($) | Vol. | No. |
---|---|---|
0.250 | 1957 | 2 |
0.260 | 19607 | 1 |
0.265 | 21010 | 2 |
0.270 | 20000 | 1 |
0.275 | 97981 | 3 |
Last trade - 09.21am 16/07/2024 (20 minute delay) ? |
Featured News
E25 (ASX) Chart |
Day chart unavailable
The Watchlist
RCE
RECCE PHARMACEUTICALS LTD
James Graham / Dr Alan Dunton, MD & CEO / Non-Executive Director
James Graham / Dr Alan Dunton
MD & CEO / Non-Executive Director
SPONSORED BY The Market Online